{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: pymysql in c:\\users\\slow\\anaconda3\\lib\\site-packages (1.0.2)\n",
      "Requirement already satisfied: sqlalchemy in c:\\users\\slow\\anaconda3\\lib\\site-packages (1.4.41)\n",
      "Requirement already satisfied: greenlet!=0.4.17; python_version >= \"3\" and (platform_machine == \"aarch64\" or (platform_machine == \"ppc64le\" or (platform_machine == \"x86_64\" or (platform_machine == \"amd64\" or (platform_machine == \"AMD64\" or (platform_machine == \"win32\" or platform_machine == \"WIN32\")))))) in c:\\users\\slow\\anaconda3\\lib\\site-packages (from sqlalchemy) (1.1.3)\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\slow\\anaconda3\\lib\\site-packages\\pandas\\core\\computation\\expressions.py:21: UserWarning: Pandas requires version '2.7.3' or newer of 'numexpr' (version '2.7.1' currently installed).\n",
      "  from pandas.core.computation.check import NUMEXPR_INSTALLED\n"
     ]
    }
   ],
   "source": [
    "!pip install pymysql sqlalchemy\n",
    "from sqlalchemy import create_engine\n",
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "MYSQL_HOSTNAME = '34.70.23.130' \n",
    "MYSQL_USER = 'steph'\n",
    "MYSQL_PASSWORD = 'ahi2022'\n",
    "MYSQL_DATABASE = 'db1'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'mysql+pymysql://steph:ahi2022@34.70.23.130/db1'"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "connection_string = f'mysql+pymysql://{MYSQL_USER}:{MYSQL_PASSWORD}@{MYSQL_HOSTNAME}/{MYSQL_DATABASE}'\n",
    "connection_string"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Engine(mysql+pymysql://steph:***@34.70.23.130/db1)"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "db1 = create_engine(connection_string)\n",
    "db1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Group</th>\n",
       "      <th>Delta</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Active</td>\n",
       "      <td>0.8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Active</td>\n",
       "      <td>0.9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Control</td>\n",
       "      <td>1.7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Active</td>\n",
       "      <td>-1.1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Control</td>\n",
       "      <td>1.7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>295</th>\n",
       "      <td>Control</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>296</th>\n",
       "      <td>Active</td>\n",
       "      <td>0.4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>297</th>\n",
       "      <td>Active</td>\n",
       "      <td>1.9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>298</th>\n",
       "      <td>Control</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>299</th>\n",
       "      <td>Active</td>\n",
       "      <td>-0.5</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>300 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       Group  Delta\n",
       "0     Active    0.8\n",
       "1     Active    0.9\n",
       "2    Control    1.7\n",
       "3     Active   -1.1\n",
       "4    Control    1.7\n",
       "..       ...    ...\n",
       "295  Control    1.0\n",
       "296   Active    0.4\n",
       "297   Active    1.9\n",
       "298  Control    0.0\n",
       "299   Active   -0.5\n",
       "\n",
       "[300 rows x 2 columns]"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df1 = pd.read_csv('https://raw.githubusercontent.com/slow312/HHA-507-2022/main/descriptive/example1/data/Cholesterol.csv')\n",
    "df1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "300"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df1.to_sql('Cholesteral',con=db1,if_exists='replace')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>index</th>\n",
       "      <th>Group</th>\n",
       "      <th>Delta</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>Active</td>\n",
       "      <td>0.8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>Active</td>\n",
       "      <td>0.9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>Control</td>\n",
       "      <td>1.7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>4</td>\n",
       "      <td>Control</td>\n",
       "      <td>1.7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>7</td>\n",
       "      <td>Control</td>\n",
       "      <td>0.8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>155</th>\n",
       "      <td>294</td>\n",
       "      <td>Active</td>\n",
       "      <td>1.2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>156</th>\n",
       "      <td>295</td>\n",
       "      <td>Control</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>157</th>\n",
       "      <td>296</td>\n",
       "      <td>Active</td>\n",
       "      <td>0.4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>158</th>\n",
       "      <td>297</td>\n",
       "      <td>Active</td>\n",
       "      <td>1.9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>159</th>\n",
       "      <td>298</td>\n",
       "      <td>Control</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>160 rows × 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     index    Group  Delta\n",
       "0        0   Active    0.8\n",
       "1        1   Active    0.9\n",
       "2        2  Control    1.7\n",
       "3        4  Control    1.7\n",
       "4        7  Control    0.8\n",
       "..     ...      ...    ...\n",
       "155    294   Active    1.2\n",
       "156    295  Control    1.0\n",
       "157    296   Active    0.4\n",
       "158    297   Active    1.9\n",
       "159    298  Control    0.0\n",
       "\n",
       "[160 rows x 3 columns]"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "query1 = \"\"\"select * from db1.Cholesteral where Delta >= 0.0\"\"\"\n",
    "CL_db_test = pd.read_sql(query1, con=db1)\n",
    "CL_db_test"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Research Activity</th>\n",
       "      <th>Project Title \\n(and link to additional information, if available)</th>\n",
       "      <th>Topic</th>\n",
       "      <th>Agency and Office Name</th>\n",
       "      <th>Country(ies) in which research is/will be conducted</th>\n",
       "      <th>Status</th>\n",
       "      <th>Upcoming Milestones</th>\n",
       "      <th>Anticipated Completion</th>\n",
       "      <th>Brief Description</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Vaccine Immunogenicity Study</td>\n",
       "      <td>A Multicenter Trial Evaluating Alterative Dosi...</td>\n",
       "      <td>Vaccine</td>\n",
       "      <td>NIH/NIAID</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Active</td>\n",
       "      <td>2023 Q1: Initial immunogenicity analysis (peak...</td>\n",
       "      <td>2023 Q2</td>\n",
       "      <td>This study is a Phase 2 randomized, open-label...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Vaccine Effectiveness Study</td>\n",
       "      <td>National estimates of post-licensure vaccine p...</td>\n",
       "      <td>Vaccine</td>\n",
       "      <td>CDC</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Planned</td>\n",
       "      <td>2022 Q3: begin project data collection</td>\n",
       "      <td>2023 Q4: multi-jurisdictional case-control study</td>\n",
       "      <td>CDC will: 1) Collect data from states and loca...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Vaccine Effectiveness Case Series Evaluation</td>\n",
       "      <td>Post-vaccination case series</td>\n",
       "      <td>Vaccine</td>\n",
       "      <td>CDC</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Planned</td>\n",
       "      <td>2022 Q3: project will begin data collection</td>\n",
       "      <td>Ongoing throughout vaccination</td>\n",
       "      <td>This is a post-vaccination case series to coll...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Vaccine Utilization Study</td>\n",
       "      <td>Evaluating vaccine administration data</td>\n",
       "      <td>Vaccine</td>\n",
       "      <td>CDC</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing;</td>\n",
       "      <td>2022 Q3: project will begin data collection</td>\n",
       "      <td>Ongoing throughout vaccination</td>\n",
       "      <td>Vaccine administration data is being collected...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Vaccine Safety Surveillance</td>\n",
       "      <td>Monitoring safety and adverse events</td>\n",
       "      <td>Vaccine</td>\n",
       "      <td>CDC</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>2022 Q4: v-safe will begin data collection</td>\n",
       "      <td>Ongoing throughout vaccination</td>\n",
       "      <td>Efforts include spontaneous reporting to Vacci...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Vaccine Immunogenicity Study</td>\n",
       "      <td>Evaluating immune response to JYNNEOS vaccine</td>\n",
       "      <td>Vaccine</td>\n",
       "      <td>CDC</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>2022 Q3: project will begin data collection</td>\n",
       "      <td>2023 Q2</td>\n",
       "      <td>Conducted in collaboration with DC Health of H...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Next Generation Vaccine Research</td>\n",
       "      <td>Development of mRNA-based monkeypox vaccines a...</td>\n",
       "      <td>Vaccine</td>\n",
       "      <td>NIH/NIAID</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>NIAID Vaccine Research Center (VRC) is develop...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Next Generation Vaccine Research</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Vaccine</td>\n",
       "      <td>NIH/NIAID</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>2022 Q4 Study initiated</td>\n",
       "      <td>2023 Q4</td>\n",
       "      <td>This study includes testing a portfolio of wel...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Observational Study</td>\n",
       "      <td>Observational studies to understand epidemiolo...</td>\n",
       "      <td>Epidemiology</td>\n",
       "      <td>CDC</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>2022 Q3: Complete sample collection \\n\\n2022 Q...</td>\n",
       "      <td>2022 Q4</td>\n",
       "      <td>CDC will investigate cases reported in special...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Observational Study</td>\n",
       "      <td>Two retrospective seroprevalence surveys in th...</td>\n",
       "      <td>Epidemiology</td>\n",
       "      <td>CDC</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>2022 Q4: Results expected for first study. Ini...</td>\n",
       "      <td>2023 Q2</td>\n",
       "      <td>Investigate monkeypox virus infection occurrin...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>Serologic assay development</td>\n",
       "      <td>High-throughput serologic assay to distinguish...</td>\n",
       "      <td>Epidemiology</td>\n",
       "      <td>NIH/NIAID</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>NIAID scientists from the PREMISE initiative a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Virulence Potential Study</td>\n",
       "      <td>Evaluating the virulence of contemporary isola...</td>\n",
       "      <td>Epidemiology</td>\n",
       "      <td>NIH/NIAID</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>2022 Q4: Results expected</td>\n",
       "      <td>2022 Q4</td>\n",
       "      <td>This study compares virulence of the 2022 monk...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Transmission Study</td>\n",
       "      <td>Exploration of fomite and aerosol survival and...</td>\n",
       "      <td>Epidemiology</td>\n",
       "      <td>NIH/NIAID</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>2022 Q3: Results expected</td>\n",
       "      <td>2022 Q3</td>\n",
       "      <td>Efforts include survival of monkeypox virus on...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Human-Animal Interface Study</td>\n",
       "      <td>CDC diagnostic laboratory support for monkeypo...</td>\n",
       "      <td>Epidemiology</td>\n",
       "      <td>CDC</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>2022 Q3: initial results expected</td>\n",
       "      <td>Ongoing throughout the outbreak</td>\n",
       "      <td>Animals, both domestic and wildlife, with clin...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Human-Animal Environment Study</td>\n",
       "      <td>Assessing monkeypox infections in animals asso...</td>\n",
       "      <td>Epidemiology</td>\n",
       "      <td>CDC</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>2022 Q4, report preliminary data.         2023...</td>\n",
       "      <td>Ongoing during the outbreak</td>\n",
       "      <td>CDC is leading a One Health study to assess mo...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Human-Animal Environment Study</td>\n",
       "      <td>Ecological studies</td>\n",
       "      <td>Epidemiology</td>\n",
       "      <td>NIH/NIAID</td>\n",
       "      <td>International: Republic of Congo (RoC); Ghana</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NIH has been conducting ecological studies in ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>Serologic assay development and serosurvey</td>\n",
       "      <td>Developing high throughput serologic assays to...</td>\n",
       "      <td>Epidemiology</td>\n",
       "      <td>NIH/NIAID</td>\n",
       "      <td>International: Mali, Ghana, Republic of the Co...</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>2022 Q4 team to Ghana</td>\n",
       "      <td>NaN</td>\n",
       "      <td>These assays will allow us to determine a hist...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Clinical Specimen Study</td>\n",
       "      <td>Novel specimen validation</td>\n",
       "      <td>Epidemiology</td>\n",
       "      <td>CDC</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>2022 Q3: Begin laboratory testing \\n\\n2022 Q4:...</td>\n",
       "      <td>2023 Q1</td>\n",
       "      <td>This is a study in collaboration with D.C. Pub...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>Clinical Specimen Study</td>\n",
       "      <td>Self-collection of Specimens</td>\n",
       "      <td>Epidemiology</td>\n",
       "      <td>CDC</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2022 Q3: Site selected and protocol developed....</td>\n",
       "      <td>2023 Q3</td>\n",
       "      <td>In conjunction with the Georgia Department of ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>Molecular Epidemiology Study</td>\n",
       "      <td>Genomic surveillance to monitor viral evolutio...</td>\n",
       "      <td>Epidemiology</td>\n",
       "      <td>CDC</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>2022 Q3: publish 100 US monkeypox virus genome...</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>This study will monitor monkeypox virus lineag...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>Therapeutic Efficacy Study</td>\n",
       "      <td>STOMP (Study of Tecovirimat for treatment of h...</td>\n",
       "      <td>Therapeutic</td>\n",
       "      <td>NIH/NIAID</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>2022 Q3: Initiate study\\n\\n2022 Q4: Close to a...</td>\n",
       "      <td>2023 Q2</td>\n",
       "      <td>This is a phase 3 double-blind, randomized con...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>Therapeutic Efficacy Study</td>\n",
       "      <td>PALM007 trial in the Democratic Republic of Co...</td>\n",
       "      <td>Therapeutic</td>\n",
       "      <td>NIH/NIAID</td>\n",
       "      <td>International: DRC</td>\n",
       "      <td>Planned</td>\n",
       "      <td>2022 Q3: Initiate study</td>\n",
       "      <td>2023 Q3</td>\n",
       "      <td>This is an in-patient double-bind, randomized,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>Therapeutic Monoclonal antibody Development</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Therapeutic</td>\n",
       "      <td>NIH/NIAID</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>2022 Q4: Study initiated</td>\n",
       "      <td>2023 Q4</td>\n",
       "      <td>Study includes testing of approximately 6 mono...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>Outreach and Communication Activities [Outreach]</td>\n",
       "      <td>Communication and engagement strategies for hi...</td>\n",
       "      <td>Outreach</td>\n",
       "      <td>CDC</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>2022 Q3: initial results expected</td>\n",
       "      <td>2023 Q1</td>\n",
       "      <td>This effort includes development of an extensi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>Diagnostic Development</td>\n",
       "      <td>Development of rapid monkeypox diagnostic test...</td>\n",
       "      <td>Diagnostic</td>\n",
       "      <td>NIH/NIBIB</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>2022 Q4: start EUA-enabling clinical studies</td>\n",
       "      <td>2023 Q1</td>\n",
       "      <td>Efforts include working with the U.S. Departme...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>Diagnostic Development</td>\n",
       "      <td>Monkeypox Virus Diagnostic on Next Generation ...</td>\n",
       "      <td>Diagnostic</td>\n",
       "      <td>DOD/JPEO</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Planning phases</td>\n",
       "      <td>Oct 2022: Initiate award to performer</td>\n",
       "      <td>2023 Q1: Anticipated Emergency Use Authorization</td>\n",
       "      <td>DOD/JPEO-CBRND will develop a Monkeypox Emerge...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>Monoclonal Antibody (mAb) Development Efforts</td>\n",
       "      <td>Generative Unconstrained Intelligent Drug Engi...</td>\n",
       "      <td>Therapeutic</td>\n",
       "      <td>DOD/JPEO</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Planning phases</td>\n",
       "      <td>2022 Q4: GUIDE optimization.\\n\\n2023 Q1:  mAb ...</td>\n",
       "      <td>2023 Q1: GUIDE completion \\n\\n2025 Q1: mAb Pha...</td>\n",
       "      <td>Through the DOD/CBDP/JPEO-CBRND Accelerated An...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>Therapeutic Development</td>\n",
       "      <td>Novel Compound Screening</td>\n",
       "      <td>Therapeutic</td>\n",
       "      <td>NIH/NIAID\\n\\nUSAMRIID</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>Screen Novel Compounds for activity against mu...</td>\n",
       "      <td>2023-09-30T00:00:00.000</td>\n",
       "      <td>USAMRIID and NIAID are collaborating to screen...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>Education and Training</td>\n",
       "      <td>Sample Collection Training and Capacity Building</td>\n",
       "      <td>Education</td>\n",
       "      <td>DTRA/WRAIR</td>\n",
       "      <td>International: West Africa</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>2022 Q1: Initial training iteration completed....</td>\n",
       "      <td>2023-09-30T00:00:00.000</td>\n",
       "      <td>WRAIR, through the Joint West African Research...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>Laboratory Safety</td>\n",
       "      <td>Inactivation validation for Biological Select ...</td>\n",
       "      <td>Lab Safety</td>\n",
       "      <td>USAMRIID</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>Validation of relevant clinical matrices to in...</td>\n",
       "      <td>2022 Q4</td>\n",
       "      <td>USAMRIID is validating Trizol for multiple Bio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>Diagnostic Assay Development</td>\n",
       "      <td>Diagnostic Assay Development</td>\n",
       "      <td>Diagnostic</td>\n",
       "      <td>DTRA JSTO/ USAMRIID</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>2022 Q3: Evaluate recombinant proteins/peptide...</td>\n",
       "      <td>2023-09-30T00:00:00.000</td>\n",
       "      <td>Current project with USAMRIID is to develop re...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>Diagnostic Assay Development</td>\n",
       "      <td>Diagnostic Assay Development</td>\n",
       "      <td>Diagnostic</td>\n",
       "      <td>DTRA/JSTO/ USAMRIID</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Completed</td>\n",
       "      <td>MPXV-specific, real-time PCR assay</td>\n",
       "      <td>NaN</td>\n",
       "      <td>USAMRIID developed a monkeypox virus-specific,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>Enhanced Diagnostics/Detection</td>\n",
       "      <td>Development of an expeditionary sequencing and...</td>\n",
       "      <td>Diagnostic</td>\n",
       "      <td>NMRC, NRL, DARPA,</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>Oct 2022:  Software component - Obtain additio...</td>\n",
       "      <td>Software Development Completion:  May 2023; Es...</td>\n",
       "      <td>Project focused on developing an expeditionary...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>Real World Vaccine Efficacy Study Using VA Data</td>\n",
       "      <td>Effectiveness of Dryvaxx®, ACAM2000 and JYNNEO...</td>\n",
       "      <td>Vaccine</td>\n",
       "      <td>VA/VHA, AFHSD/ DHA</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Initiated</td>\n",
       "      <td>Cleaning data; Defining cases; Defining outcom...</td>\n",
       "      <td>2023-01-31T00:00:00.000</td>\n",
       "      <td>This is an analysis of VA and DoD data to expl...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>Analysis of the VA Patient Population Affected...</td>\n",
       "      <td>Monkeypox in Veterans Affairs Healthcare System</td>\n",
       "      <td>Epidemiology</td>\n",
       "      <td>VA</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Planning</td>\n",
       "      <td>1) Creating research team  \\n\\n2) Designing st...</td>\n",
       "      <td>2023-03-31T00:00:00.000</td>\n",
       "      <td>Description and comparison of unique populatio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>Biorepository System</td>\n",
       "      <td>Veterans Affairs Science and Health Initiative...</td>\n",
       "      <td>Epidemiology</td>\n",
       "      <td>VA/VHA</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Initiated</td>\n",
       "      <td>Specimens collected; Specimens used for resear...</td>\n",
       "      <td>Ongoing part of VA’s research pandemic prepare...</td>\n",
       "      <td>VA SHIELD collects de-identified biological sa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>Monitoring International Monkeypox Infections</td>\n",
       "      <td>No formal research protocol – monitoring the e...</td>\n",
       "      <td>Epidemiology</td>\n",
       "      <td>DOS/S/GAC</td>\n",
       "      <td>International: Countries with PEPFAR programs ...</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>None</td>\n",
       "      <td>TBD</td>\n",
       "      <td>Through communication with U.S. Government in-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>International Training and equipment upgrades/...</td>\n",
       "      <td>Enhancing Biosafety and Biosecurity of High Co...</td>\n",
       "      <td>Education</td>\n",
       "      <td>DOS/ISN</td>\n",
       "      <td>International: DRC</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>In-person workshop in October 2022</td>\n",
       "      <td>End of December 2022</td>\n",
       "      <td>Through a series of virtual biosafety and bios...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>Structural biology studies in support of vacci...</td>\n",
       "      <td>X-ray crystallography studies at the Advanced ...</td>\n",
       "      <td>Vaccine, Therapeutic</td>\n",
       "      <td>DOE</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Most protein structures deposited in the Prote...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>Structural biology studies in support of vacci...</td>\n",
       "      <td>X-ray crystallography studies at the Stanford ...</td>\n",
       "      <td>Vaccine, Therapeutic</td>\n",
       "      <td>DOE</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Stanford Synchrotron Radiation Light Source at...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>Computational studies of phylogeny and predict...</td>\n",
       "      <td>Computational studies of monkey pox protein an...</td>\n",
       "      <td>Epidemiology</td>\n",
       "      <td>DOE</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Argonne (in a collaboration with University of...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>Monkeypox Virus detection</td>\n",
       "      <td>Sequencing monkey pox virus from Chicago area ...</td>\n",
       "      <td>Epidemiology</td>\n",
       "      <td>DOE</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Scientists at Argonne are sequencing monkeypox...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>Evolution of monkeypox</td>\n",
       "      <td>Assessment of human enzyme cAPOBEC3 impacts on...</td>\n",
       "      <td>Epidemiology</td>\n",
       "      <td>DOE</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Scientists at Los Alamos recognized a very unu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>Virus genome sequencing</td>\n",
       "      <td>Challenges in sequencing and assembling monkey...</td>\n",
       "      <td>Epidemiology</td>\n",
       "      <td>DOE</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Scientists at Los Alamos are advising the CDC ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>Molecular Therapeutics</td>\n",
       "      <td>Computational design of potential pan-orthopox...</td>\n",
       "      <td>Therapeutic</td>\n",
       "      <td>DOE</td>\n",
       "      <td>Domestic</td>\n",
       "      <td>Planned</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Lawrence Livermore is conducting studies as pa...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                    Research Activity  \\\n",
       "0                        Vaccine Immunogenicity Study   \n",
       "1                         Vaccine Effectiveness Study   \n",
       "2        Vaccine Effectiveness Case Series Evaluation   \n",
       "3                           Vaccine Utilization Study   \n",
       "4                         Vaccine Safety Surveillance   \n",
       "5                        Vaccine Immunogenicity Study   \n",
       "6                    Next Generation Vaccine Research   \n",
       "7                    Next Generation Vaccine Research   \n",
       "8                                 Observational Study   \n",
       "9                                 Observational Study   \n",
       "10                        Serologic assay development   \n",
       "11                          Virulence Potential Study   \n",
       "12                                 Transmission Study   \n",
       "13                       Human-Animal Interface Study   \n",
       "14                     Human-Animal Environment Study   \n",
       "15                     Human-Animal Environment Study   \n",
       "16         Serologic assay development and serosurvey   \n",
       "17                            Clinical Specimen Study   \n",
       "18                            Clinical Specimen Study   \n",
       "19                       Molecular Epidemiology Study   \n",
       "20                         Therapeutic Efficacy Study   \n",
       "21                         Therapeutic Efficacy Study   \n",
       "22        Therapeutic Monoclonal antibody Development   \n",
       "23   Outreach and Communication Activities [Outreach]   \n",
       "24                             Diagnostic Development   \n",
       "25                             Diagnostic Development   \n",
       "26      Monoclonal Antibody (mAb) Development Efforts   \n",
       "27                            Therapeutic Development   \n",
       "28                             Education and Training   \n",
       "29                                  Laboratory Safety   \n",
       "30                       Diagnostic Assay Development   \n",
       "31                       Diagnostic Assay Development   \n",
       "32                     Enhanced Diagnostics/Detection   \n",
       "33    Real World Vaccine Efficacy Study Using VA Data   \n",
       "34  Analysis of the VA Patient Population Affected...   \n",
       "35                               Biorepository System   \n",
       "36      Monitoring International Monkeypox Infections   \n",
       "37  International Training and equipment upgrades/...   \n",
       "38  Structural biology studies in support of vacci...   \n",
       "39  Structural biology studies in support of vacci...   \n",
       "40  Computational studies of phylogeny and predict...   \n",
       "41                          Monkeypox Virus detection   \n",
       "42                             Evolution of monkeypox   \n",
       "43                            Virus genome sequencing   \n",
       "44                             Molecular Therapeutics   \n",
       "\n",
       "   Project Title \\n(and link to additional information, if available)  \\\n",
       "0   A Multicenter Trial Evaluating Alterative Dosi...                   \n",
       "1   National estimates of post-licensure vaccine p...                   \n",
       "2                        Post-vaccination case series                   \n",
       "3              Evaluating vaccine administration data                   \n",
       "4                Monitoring safety and adverse events                   \n",
       "5       Evaluating immune response to JYNNEOS vaccine                   \n",
       "6   Development of mRNA-based monkeypox vaccines a...                   \n",
       "7                                                 NaN                   \n",
       "8   Observational studies to understand epidemiolo...                   \n",
       "9   Two retrospective seroprevalence surveys in th...                   \n",
       "10  High-throughput serologic assay to distinguish...                   \n",
       "11  Evaluating the virulence of contemporary isola...                   \n",
       "12  Exploration of fomite and aerosol survival and...                   \n",
       "13  CDC diagnostic laboratory support for monkeypo...                   \n",
       "14  Assessing monkeypox infections in animals asso...                   \n",
       "15                                 Ecological studies                   \n",
       "16  Developing high throughput serologic assays to...                   \n",
       "17                          Novel specimen validation                   \n",
       "18                       Self-collection of Specimens                   \n",
       "19  Genomic surveillance to monitor viral evolutio...                   \n",
       "20  STOMP (Study of Tecovirimat for treatment of h...                   \n",
       "21  PALM007 trial in the Democratic Republic of Co...                   \n",
       "22                                                NaN                   \n",
       "23  Communication and engagement strategies for hi...                   \n",
       "24  Development of rapid monkeypox diagnostic test...                   \n",
       "25  Monkeypox Virus Diagnostic on Next Generation ...                   \n",
       "26  Generative Unconstrained Intelligent Drug Engi...                   \n",
       "27                           Novel Compound Screening                   \n",
       "28   Sample Collection Training and Capacity Building                   \n",
       "29  Inactivation validation for Biological Select ...                   \n",
       "30                       Diagnostic Assay Development                   \n",
       "31                       Diagnostic Assay Development                   \n",
       "32  Development of an expeditionary sequencing and...                   \n",
       "33  Effectiveness of Dryvaxx®, ACAM2000 and JYNNEO...                   \n",
       "34    Monkeypox in Veterans Affairs Healthcare System                   \n",
       "35  Veterans Affairs Science and Health Initiative...                   \n",
       "36  No formal research protocol – monitoring the e...                   \n",
       "37  Enhancing Biosafety and Biosecurity of High Co...                   \n",
       "38  X-ray crystallography studies at the Advanced ...                   \n",
       "39  X-ray crystallography studies at the Stanford ...                   \n",
       "40  Computational studies of monkey pox protein an...                   \n",
       "41  Sequencing monkey pox virus from Chicago area ...                   \n",
       "42  Assessment of human enzyme cAPOBEC3 impacts on...                   \n",
       "43  Challenges in sequencing and assembling monkey...                   \n",
       "44  Computational design of potential pan-orthopox...                   \n",
       "\n",
       "                   Topic Agency and Office Name  \\\n",
       "0                Vaccine              NIH/NIAID   \n",
       "1                Vaccine                    CDC   \n",
       "2                Vaccine                    CDC   \n",
       "3                Vaccine                    CDC   \n",
       "4                Vaccine                    CDC   \n",
       "5                Vaccine                    CDC   \n",
       "6                Vaccine              NIH/NIAID   \n",
       "7                Vaccine              NIH/NIAID   \n",
       "8           Epidemiology                    CDC   \n",
       "9           Epidemiology                    CDC   \n",
       "10          Epidemiology              NIH/NIAID   \n",
       "11          Epidemiology              NIH/NIAID   \n",
       "12          Epidemiology              NIH/NIAID   \n",
       "13          Epidemiology                    CDC   \n",
       "14          Epidemiology                    CDC   \n",
       "15          Epidemiology              NIH/NIAID   \n",
       "16          Epidemiology              NIH/NIAID   \n",
       "17          Epidemiology                    CDC   \n",
       "18          Epidemiology                    CDC   \n",
       "19          Epidemiology                    CDC   \n",
       "20           Therapeutic              NIH/NIAID   \n",
       "21           Therapeutic              NIH/NIAID   \n",
       "22           Therapeutic              NIH/NIAID   \n",
       "23              Outreach                    CDC   \n",
       "24            Diagnostic              NIH/NIBIB   \n",
       "25            Diagnostic               DOD/JPEO   \n",
       "26           Therapeutic               DOD/JPEO   \n",
       "27           Therapeutic  NIH/NIAID\\n\\nUSAMRIID   \n",
       "28             Education             DTRA/WRAIR   \n",
       "29            Lab Safety               USAMRIID   \n",
       "30            Diagnostic    DTRA JSTO/ USAMRIID   \n",
       "31            Diagnostic    DTRA/JSTO/ USAMRIID   \n",
       "32            Diagnostic      NMRC, NRL, DARPA,   \n",
       "33               Vaccine     VA/VHA, AFHSD/ DHA   \n",
       "34          Epidemiology                     VA   \n",
       "35          Epidemiology                 VA/VHA   \n",
       "36          Epidemiology              DOS/S/GAC   \n",
       "37             Education                DOS/ISN   \n",
       "38  Vaccine, Therapeutic                    DOE   \n",
       "39  Vaccine, Therapeutic                    DOE   \n",
       "40          Epidemiology                    DOE   \n",
       "41          Epidemiology                    DOE   \n",
       "42          Epidemiology                    DOE   \n",
       "43          Epidemiology                    DOE   \n",
       "44           Therapeutic                    DOE   \n",
       "\n",
       "   Country(ies) in which research is/will be conducted           Status  \\\n",
       "0                                            Domestic            Active   \n",
       "1                                            Domestic           Planned   \n",
       "2                                            Domestic           Planned   \n",
       "3                                            Domestic          Ongoing;   \n",
       "4                                            Domestic           Ongoing   \n",
       "5                                            Domestic           Ongoing   \n",
       "6                                            Domestic           Ongoing   \n",
       "7                                            Domestic           Ongoing   \n",
       "8                                            Domestic           Ongoing   \n",
       "9                                            Domestic           Ongoing   \n",
       "10                                           Domestic           Ongoing   \n",
       "11                                           Domestic           Ongoing   \n",
       "12                                           Domestic           Ongoing   \n",
       "13                                           Domestic           Ongoing   \n",
       "14                                           Domestic           Ongoing   \n",
       "15      International: Republic of Congo (RoC); Ghana           Ongoing   \n",
       "16  International: Mali, Ghana, Republic of the Co...           Ongoing   \n",
       "17                                           Domestic           Ongoing   \n",
       "18                                           Domestic               NaN   \n",
       "19                                           Domestic           Ongoing   \n",
       "20                                           Domestic           Ongoing   \n",
       "21                                 International: DRC           Planned   \n",
       "22                                           Domestic           Ongoing   \n",
       "23                                           Domestic           Ongoing   \n",
       "24                                           Domestic           Ongoing   \n",
       "25                                           Domestic   Planning phases   \n",
       "26                                           Domestic   Planning phases   \n",
       "27                                           Domestic           Ongoing   \n",
       "28                         International: West Africa           Ongoing   \n",
       "29                                           Domestic           Ongoing   \n",
       "30                                           Domestic           Ongoing   \n",
       "31                                           Domestic         Completed   \n",
       "32                                           Domestic           Ongoing   \n",
       "33                                           Domestic         Initiated   \n",
       "34                                           Domestic          Planning   \n",
       "35                                           Domestic         Initiated   \n",
       "36  International: Countries with PEPFAR programs ...           Ongoing   \n",
       "37                                 International: DRC           Ongoing   \n",
       "38                                           Domestic           Ongoing   \n",
       "39                                           Domestic           Ongoing   \n",
       "40                                           Domestic           Ongoing   \n",
       "41                                           Domestic           Ongoing   \n",
       "42                                           Domestic           Ongoing   \n",
       "43                                           Domestic           Ongoing   \n",
       "44                                           Domestic           Planned   \n",
       "\n",
       "                                  Upcoming Milestones  \\\n",
       "0   2023 Q1: Initial immunogenicity analysis (peak...   \n",
       "1              2022 Q3: begin project data collection   \n",
       "2         2022 Q3: project will begin data collection   \n",
       "3         2022 Q3: project will begin data collection   \n",
       "4          2022 Q4: v-safe will begin data collection   \n",
       "5         2022 Q3: project will begin data collection   \n",
       "6                                                 NaN   \n",
       "7                             2022 Q4 Study initiated   \n",
       "8   2022 Q3: Complete sample collection \\n\\n2022 Q...   \n",
       "9   2022 Q4: Results expected for first study. Ini...   \n",
       "10                                                NaN   \n",
       "11                          2022 Q4: Results expected   \n",
       "12                          2022 Q3: Results expected   \n",
       "13                  2022 Q3: initial results expected   \n",
       "14  2022 Q4, report preliminary data.         2023...   \n",
       "15                                                NaN   \n",
       "16                              2022 Q4 team to Ghana   \n",
       "17  2022 Q3: Begin laboratory testing \\n\\n2022 Q4:...   \n",
       "18  2022 Q3: Site selected and protocol developed....   \n",
       "19  2022 Q3: publish 100 US monkeypox virus genome...   \n",
       "20  2022 Q3: Initiate study\\n\\n2022 Q4: Close to a...   \n",
       "21                            2022 Q3: Initiate study   \n",
       "22                           2022 Q4: Study initiated   \n",
       "23                  2022 Q3: initial results expected   \n",
       "24       2022 Q4: start EUA-enabling clinical studies   \n",
       "25              Oct 2022: Initiate award to performer   \n",
       "26  2022 Q4: GUIDE optimization.\\n\\n2023 Q1:  mAb ...   \n",
       "27  Screen Novel Compounds for activity against mu...   \n",
       "28  2022 Q1: Initial training iteration completed....   \n",
       "29  Validation of relevant clinical matrices to in...   \n",
       "30  2022 Q3: Evaluate recombinant proteins/peptide...   \n",
       "31                 MPXV-specific, real-time PCR assay   \n",
       "32  Oct 2022:  Software component - Obtain additio...   \n",
       "33  Cleaning data; Defining cases; Defining outcom...   \n",
       "34  1) Creating research team  \\n\\n2) Designing st...   \n",
       "35  Specimens collected; Specimens used for resear...   \n",
       "36                                               None   \n",
       "37                 In-person workshop in October 2022   \n",
       "38                                                NaN   \n",
       "39                                                NaN   \n",
       "40                                                NaN   \n",
       "41                                                NaN   \n",
       "42                                                NaN   \n",
       "43                                                NaN   \n",
       "44                                                NaN   \n",
       "\n",
       "                               Anticipated Completion  \\\n",
       "0                                             2023 Q2   \n",
       "1    2023 Q4: multi-jurisdictional case-control study   \n",
       "2                      Ongoing throughout vaccination   \n",
       "3                      Ongoing throughout vaccination   \n",
       "4                      Ongoing throughout vaccination   \n",
       "5                                             2023 Q2   \n",
       "6                                             Ongoing   \n",
       "7                                             2023 Q4   \n",
       "8                                             2022 Q4   \n",
       "9                                             2023 Q2   \n",
       "10                                            Ongoing   \n",
       "11                                            2022 Q4   \n",
       "12                                            2022 Q3   \n",
       "13                    Ongoing throughout the outbreak   \n",
       "14                        Ongoing during the outbreak   \n",
       "15                                                NaN   \n",
       "16                                                NaN   \n",
       "17                                            2023 Q1   \n",
       "18                                            2023 Q3   \n",
       "19                                            Ongoing   \n",
       "20                                            2023 Q2   \n",
       "21                                            2023 Q3   \n",
       "22                                            2023 Q4   \n",
       "23                                            2023 Q1   \n",
       "24                                            2023 Q1   \n",
       "25   2023 Q1: Anticipated Emergency Use Authorization   \n",
       "26  2023 Q1: GUIDE completion \\n\\n2025 Q1: mAb Pha...   \n",
       "27                            2023-09-30T00:00:00.000   \n",
       "28                            2023-09-30T00:00:00.000   \n",
       "29                                            2022 Q4   \n",
       "30                            2023-09-30T00:00:00.000   \n",
       "31                                                NaN   \n",
       "32  Software Development Completion:  May 2023; Es...   \n",
       "33                            2023-01-31T00:00:00.000   \n",
       "34                            2023-03-31T00:00:00.000   \n",
       "35  Ongoing part of VA’s research pandemic prepare...   \n",
       "36                                                TBD   \n",
       "37                               End of December 2022   \n",
       "38                                                NaN   \n",
       "39                                                NaN   \n",
       "40                                                NaN   \n",
       "41                                                NaN   \n",
       "42                                                NaN   \n",
       "43                                                NaN   \n",
       "44                                                NaN   \n",
       "\n",
       "                                    Brief Description  \n",
       "0   This study is a Phase 2 randomized, open-label...  \n",
       "1   CDC will: 1) Collect data from states and loca...  \n",
       "2   This is a post-vaccination case series to coll...  \n",
       "3   Vaccine administration data is being collected...  \n",
       "4   Efforts include spontaneous reporting to Vacci...  \n",
       "5   Conducted in collaboration with DC Health of H...  \n",
       "6   NIAID Vaccine Research Center (VRC) is develop...  \n",
       "7   This study includes testing a portfolio of wel...  \n",
       "8   CDC will investigate cases reported in special...  \n",
       "9   Investigate monkeypox virus infection occurrin...  \n",
       "10  NIAID scientists from the PREMISE initiative a...  \n",
       "11  This study compares virulence of the 2022 monk...  \n",
       "12  Efforts include survival of monkeypox virus on...  \n",
       "13  Animals, both domestic and wildlife, with clin...  \n",
       "14  CDC is leading a One Health study to assess mo...  \n",
       "15  NIH has been conducting ecological studies in ...  \n",
       "16  These assays will allow us to determine a hist...  \n",
       "17  This is a study in collaboration with D.C. Pub...  \n",
       "18  In conjunction with the Georgia Department of ...  \n",
       "19  This study will monitor monkeypox virus lineag...  \n",
       "20  This is a phase 3 double-blind, randomized con...  \n",
       "21  This is an in-patient double-bind, randomized,...  \n",
       "22  Study includes testing of approximately 6 mono...  \n",
       "23  This effort includes development of an extensi...  \n",
       "24  Efforts include working with the U.S. Departme...  \n",
       "25  DOD/JPEO-CBRND will develop a Monkeypox Emerge...  \n",
       "26  Through the DOD/CBDP/JPEO-CBRND Accelerated An...  \n",
       "27  USAMRIID and NIAID are collaborating to screen...  \n",
       "28  WRAIR, through the Joint West African Research...  \n",
       "29  USAMRIID is validating Trizol for multiple Bio...  \n",
       "30  Current project with USAMRIID is to develop re...  \n",
       "31  USAMRIID developed a monkeypox virus-specific,...  \n",
       "32  Project focused on developing an expeditionary...  \n",
       "33  This is an analysis of VA and DoD data to expl...  \n",
       "34  Description and comparison of unique populatio...  \n",
       "35  VA SHIELD collects de-identified biological sa...  \n",
       "36  Through communication with U.S. Government in-...  \n",
       "37  Through a series of virtual biosafety and bios...  \n",
       "38  Most protein structures deposited in the Prote...  \n",
       "39  Stanford Synchrotron Radiation Light Source at...  \n",
       "40  Argonne (in a collaboration with University of...  \n",
       "41  Scientists at Argonne are sequencing monkeypox...  \n",
       "42  Scientists at Los Alamos recognized a very unu...  \n",
       "43  Scientists at Los Alamos are advising the CDC ...  \n",
       "44  Lawrence Livermore is conducting studies as pa...  "
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df2 = pd.read_csv('C:/Users/slow/AHI/HHA-504/mysql-selfmanaged/data/Monkeypox_Research_Summary_Data.csv')\n",
    "df2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['Research Activity', 'Project Title', 'Topic', 'Agency and Office Name',\n",
       "       'Country(ies) in which research is/will be conducted', 'Status',\n",
       "       'Upcoming Milestones', 'Anticipated Completion', 'Brief Description'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df2 = df2.rename({'Project Title \\n(and link to additional information, if available)': 'Project Title'}, axis=1)\n",
    "df2.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "45"
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df2.to_sql('Monkeypox',con=db1,if_exists='replace')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
